William Rose - Aug 23, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director
Signature
/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose
Stock symbol
RETA
Transactions as of
Aug 23, 2023
Transactions value $
$0
Form type
4
Date filed
8/24/2023, 04:41 PM
Previous filing
Jun 9, 2023
Next filing
Sep 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Gift $0 -500K -56.86% $0.00 379K Aug 23, 2023 By trust F1, F2
holding RETA Class A common stock 11.6K Aug 23, 2023 Direct F3
holding RETA Class A common stock 19.8K Aug 23, 2023 Direct F4
holding RETA Class A common stock 7.89K Aug 23, 2023 See Footnote F5
holding RETA Class A common stock 20 Aug 23, 2023 By trust F6
holding RETA Class A common stock 45 Aug 23, 2023 By trust F7
holding RETA Class A common stock 29 Aug 23, 2023 See Footnote F8
holding RETA Class A common stock 181K Aug 23, 2023 See Footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the donative transfer of shares of Class A common stock. On August 23, 2023, these 500,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family charitable foundation.
F2 These shares are owned directly by the Evelyn Potter Rose Survivor's Trust, for which Charles E. Gale and Evelyn P. Rose serve as co-trustees.
F3 These shares are owned directly by William E. Rose, a director of the issuer.
F4 These shares are owned directly by Charles E. Gale.
F5 These shares are owned directly by Evelyn P. Rose Fidelity SEP IRA and indirectly by Evelyn R. Rose.
F6 These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the Charles Henry Rose 2001 Trust.
F7 These shares are owned indirectly by William E. Rose, a director of the issuer, as co-trustee of the John William Rose 2002 Trust.
F8 These shares are owned directly by the Charles E. Gale Fidelity Rollover IRA and indirectly by Charles E. Gale.
F9 These shares are owned directly by Montrose Investments I, L.P. ("Montrose"), and indirectly by William E. Rose, a director of the issuer, as sole shareholder and sole manager of the general partner of Montrose.